Shopping Cart 0
Cart Subtotal
USD 0

Protokinetix Inc (PKTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

ProtoKinetix Inc (ProtoKinetix) is a biotechnology company that develops solutions for cell survival and health. The company develops anti-aging glycopeptides used to protect cell lines including hela cells, neonatal fibroblasts, adult fibroblast, human neuronal stem cells, CD34+ cells and keratinocytes. It anti-aging glycopeptides also have commercial applications in the harvesting, storage, and transplantation of cells, tissues, and organs. ProtoKinetix offers products for health, stem cell and dermatology applications. It serves medical researchers in the areas of regenerative medicine and therapy for diseases. The company partners with universities and private research researchers to conduct its research activities. It performs tests in various outsourced laboratories to test neuronal retinal cells in living tissue for the treatment of macular degeneration. ProtoKinetix is headquartered in Marietta, Ohio, the US.

Protokinetix Inc (PKTX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Protokinetix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Protokinetix Inc, Medical Devices Deals, 2012 to YTD 2018 9

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Protokinetix Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

ProtoKinetix Acquires Certain Patents from University of Alberta 11

Partnerships 12

ProtoKinetix Enters into Research Agreement with University of British Columbia 12

ProtoKinetix and Proactive Immune Sciences Enter into Agreement 13

ProtoKinetix Enters into Research Agreement with University of British Columbia 14

ProtoKinetix Enters into Contract Research Agreement with ITR Labs 15

Equity Offering 16

Protokinetix Raises Additional USD0.4 Million in Private Placement of Shares 16

Protokinetix Raises USD0.2 Million in Private Placement of Shares 17

ProtoKinetix Raises USD0.2 Million in First Tranche of Private Placement of Shares 18

ProtoKinetix Raises USD0.2 Million in Private Placement of Units 19

ProtoKinetix Raises USD0.12 Million in Private Placement of Common Stock 20

Protokinetix Inc-Key Competitors 21

Protokinetix Inc-Key Employees 22

Protokinetix Inc-Locations And Subsidiaries 23

Head Office 23

Recent Developments 24

Legal and Regulatory 24

Jan 17, 2017: ProtoKinetix Announces Investigator Sponsored Clinical Trial Submitted to Health Canada for the use of AAGP in the Treatment of Type 1 Diabetes 24

Product News 25

Aug 10, 2018: ProtoKinetix enters into 3rd phase of Retinal Cell Replacement Therapy Testing at UBC 25

May 24, 2017: Protokinetix Completes First Year Of Trials On Retinal Replacement Therapy Using Aagp 26

Mar 09, 2017: Protokinetix Announces Start Of Phase 1 & Phase 2 Clinical Trials For The Use Of AAGP PKX-001 Treated Islet Cells In The Treatment Of Type 1 Diabetes 27

Jan 24, 2017: ProtoKinetix Announces Investigator Sponsored Human Clinical Trial Application Using AAGP Has Been Approved by Health Canada 28

Other Significant Developments 29

Nov 16, 2017: The Effects of ProtoKinetix' Anti-Aging Glycopeptide (AAGP) on Immune Cell Banking and Functions Relevant to Immunotherapy 29

Oct 17, 2017: Scientific Update for Diabetes, Kidney Ischemia, Liver Perfusion, Retinal Cell Replacement, Monoclonal Antibody Production and Immune Cell Cryopreservation Recovery 30

Feb 07, 2017: ProtoKinetix Updates Testing Progress on Neuronal Retinal Cells in Living Tissue for the Treatment of Macular Degeneration 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Protokinetix Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Protokinetix Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Protokinetix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Protokinetix Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Protokinetix Inc, Medical Devices Deals, 2012 to YTD 2018 9

Protokinetix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

ProtoKinetix Acquires Certain Patents from University of Alberta 11

ProtoKinetix Enters into Research Agreement with University of British Columbia 12

ProtoKinetix and Proactive Immune Sciences Enter into Agreement 13

ProtoKinetix Enters into Research Agreement with University of British Columbia 14

ProtoKinetix Enters into Contract Research Agreement with ITR Labs 15

Protokinetix Raises Additional USD0.4 Million in Private Placement of Shares 16

Protokinetix Raises USD0.2 Million in Private Placement of Shares 17

ProtoKinetix Raises USD0.2 Million in First Tranche of Private Placement of Shares 18

ProtoKinetix Raises USD0.2 Million in Private Placement of Units 19

ProtoKinetix Raises USD0.12 Million in Private Placement of Common Stock 20

Protokinetix Inc, Key Competitors 21

Protokinetix Inc, Key Employees 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Protokinetix Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.